Note some dates!
$ARS Pharmaceuticals (SPRY.US)$ Ec Marketing Authorization Expected in Q3 2024
After Grant of Marketing Authorization by Ec Expected in Q3, Expects Eurneffy to Be Made Available to Patients in Europe in Q4
Eurneffy Same Data Package Under Review by FDA With a Pdufa Date of Oct 2
After Grant of Marketing Authorization by Ec Expected in Q3, Expects Eurneffy to Be Made Available to Patients in Europe in Q4
Eurneffy Same Data Package Under Review by FDA With a Pdufa Date of Oct 2
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Monster madness : Guessing if they can get US approval also in the fall this will be a high double digit stock.
Trytosaveabit OP Monster madness : Howdy! So depending on where it’s trading at if/when that approval come? It very well could break up passed 13+! On another note. Yes this had some decent news for today. It just didn’t get much of a PI. The overall market was in pretty bad shape though. But it did get enough of a PI to finish making a nice small double bottom on the daily. So I will be watching very closely on Monday! See if the double bottom now continues and breaks upward! BTW sorry for the late reply! But Fridays I can’t be here after about 9:30AM est! I have a previous obligation that takes me away! I try to check in through the day if time permits. Like now. I had a few minutes before I jump in the truck to head home and decided to use the few free minutes to check in! Hope you had a good day.
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Monster madness : Have a great weekend, your insight is always very appreciated
Trytosaveabit OP Monster madness : Thank you! You have a great weekend as well!